FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD

The transcript discusses the use of ecstasy to treat PTSD, highlighting that current evidence does not support its effectiveness or benefits outweighing the risks. It marks the first time the FDA has considered a psychedelic drug for medical use. Despite a setback, the drug could still be approved as the FDA values but is not bound by panel recommendations.

What are the potential risks associated with the drug according to the text?

What does the FDA rely on when making decisions about drug approval?